Collectively, the data support a mechanism whereby cancer cells take up and metabolize lactate in the context of bioavailable glutamine in normoxic, but not hypoxic conditions (Figures 3B and 3C), thereby upregulating mTOR signaling (Figure 4B). The gene discussed is MTOR; the disease is cancer.